Update On Cre Infections - Fda Perspective

Update on CRE infections - FDA perspective

SAGES - Minimally Invasive Surgery Videos

Superbug infection resistant to all FDA-approved antibiotics

Drug Development Considerations for the Prevention of HAIs

Centers for Disease Control and Prevention (CDC)

FDA perspective

NASEM Health and Medicine Division

Infections with Multidrug-Resistant Organisms (MDROs)

Icahn School of Medicine

FDA approves Sivextro to treat skin infections

AGA Clinical Symposium: Duodenoscope-Associated CRE Infections

WebsEdgeMedicine

CRE Bacteria Infection : Causes, Diagnosis, Symptoms, Treatment, Prognosis

Health Is Wealth

COVID & VARIANTS UPDATE, INNOVATIONS ON THE HORIZON, CDC & FDA UPCOMING CHANGES

Roots Community Health

What Did You Discover About Duodenoscopes Infected By Superbug? | Madris Tomes, CEO of Device Events

Peter Eisler from Reuters News Agency on Medical Device Safety

Health Watch USA

FDA Approves Groundbreaking Sickle Cell Therapy Casgevy

Dr. Berry Pierre

Dr. Bret T. Petersen discusses CRE infection and ERCP

ASGE Video Tip of the Week

September 9, 2024 Meeting of the Antimicrobial Drugs Advisory Committee (AMDAC)

U.S. Food and Drug Administration

VABOMERE Shows Higher Cure Rate in Patients with CRE Infections Vs. Best Available Therapy

A new treatment for uncomplicated urinary tract infections. 🦠 #uti #medicalschool

The Curbsiders Internal Medicine Podcast

Dr. Dodson on CRE Superbug

Good Samaritan Medical Center

Carbapenem-resistant Enterobacteriaceae (CRE) Infections

X-Plain Patient Education

Renee Ackley, PharmD, BCPS: Comparing Agents for Treating CRE

Discovering the FDA-cleared Acuitas AMR Gene Panel: Building a Case for Clinical Utility